Boston Scientific Corporation

Medical Equipment
BSX
$ 40 2.2
Share price
$ 57 bn
Market Cap
$ 68 bn
Enterprise Value

Carbon footprint

0.79 Ton
GHG emissions per $ 1 mln investment
0.03x the weighted average for S&P 500
FY2020
How is this calculated?
-37%
YOY change in GHG emissions
Stronger than the -11% weighted average for S&P 500
FY2020 vs. previous year

Primary Climate Goal

-10%
Proj. YOY change in GHG emissions (Scope 1 + 2)
Stronger than the -5.1% weighted average for S&P 500
FY2021
How is this calculated?

Boston Scientific Corporation aims to achieve carbon neutrality for Scope 1 + 2 by 2030


This target has not been verified as science based according to SBTi
Boston Scientific Corporation's actual and proj. GHG emissions (Scope 1 + 2) (Kt of CO2e)

GHG emissions and Carbon intensity

Boston Scientific Corporation's GHG emissions (market-based) (Kt of CO2e)
Boston Scientific Corporation's Carbon intensity (Tons per 1 USDm)

Boston Scientific Corporation's carbon footprint

Boston Scientific Corporation reported Total CO2e Emissions - Market-Based Scope 1 + Scope 2 for the twelve months ending 31 December 2020 at 54 Kt (-31 /-36.6% y-o-y). Also positively, carbon intensity plunged to 5.4 t (-2.5 /-31.6% y-o-y).

No public disclosure of Scope 3 emissions has been found for Boston Scientific Corporation at the moment.

The company is committed to achieving carbon neutrality for Scope 1 + 2 by 2030, which translates into the estimated reduction of -5.4 Kt per annum over the period of FY2021 - FY2030. This target, however, has not been recognised as science-based (and as aligned with Paris Agreement) by the SBTi.

Boston Scientific Corporation aims to achive carbon neutrality across its operations (Scope 1 + 2) in 2030. Companies normally become carbon neutral with the help of the acquisition of carbon offsets rather than absolute reductions in their own greenhouse emissions. Also, carbon neutrality does not include non-CO2 GHG emissions.

Company environmental metrics

Show more...